Downtrend on the daily chart: below its 200-day average, above its 50-day · 50-day below the 200-day · SuperTrend down since Mar 2 · inside the Ichimoku cloud · RSI 5 (oversold) · MACD above its signal · at its 52-week low
None of the 29 investors followed here reported a position in SHWZ in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SHWZ trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for SHWZ.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | -99.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −99.5% | ||
| 2025 | 0.0 | -72.5 | 0.0 | 263.6 | 0.0 | -90.0 | 900.0 | -93.5 | -92.3 | 2100.0 | 0.0 | 0.0 | −89.0% |
| 2024 | 72.2 | 9.5 | -28.7 | -7.3 | -40.1 | -13.2 | -49.9 | -44.4 | 0.0 | 0.0 | -9.1 | -80.0 | −96.7% |
| 2023 | -0.4 | -8.5 | -12.2 | -2.9 | -15.5 | 16.1 | -16.6 | -4.4 | -8.1 | -24.1 | -9.7 | 12.5 | −56.9% |
| 2022 | -19.4 | 20.3 | 21.5 | -19.1 | -13.0 | -22.1 | -10.9 | 31.4 | -23.9 | 27.5 | 41.5 | -23.1 | −20.2% |
| 2021 | 60.4 | -2.9 | -1.7 | 23.7 | -11.7 | -3.8 | -5.0 | -3.3 | -19.1 | 15.2 | -6.8 | -7.1 | +19.1% |
| 2020 | -4.7 | -26.4 | -26.1 | 40.3 | -18.9 | 12.0 | -25.4 | -4.5 | -7.9 | -5.2 | 20.0 | 12.9 | −44.4% |
| 2019 | 60.3 | -4.5 | 13.5 | 62.1 | 1.1 | -9.7 | -7.4 | -3.8 | 25.4 | -16.8 | 1.0 | -11.8 | +112.7% |
| 2018 | 21.6 | -26.0 | -16.3 | 4.6 | 1.9 | -21.8 | -17.2 | 46.7 | -7.4 | 0.6 | -5.6 | -18.6 | −45.5% |
| 2017 | -11.7 | -20.2 | -2.5 | -9.6 | 2.9 | -20.6 | -0.7 | -15.9 | -12.9 | 28.7 | 37.7 | 29.1 | −15.7% |
| 2016 | -7.6 | -7.7 | 0.0 | -1.4 | 7.1 | -16.4 | 10.2 | 151.4 | -36.4 | -2.1 | +29.9% |
No analyst coverage for this instrument.
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R. Greenleaf brand names. In addition, the company sells indoor gardening supplies and hydroponics through its online and retail store. Medicine Man Technologies, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.
No recent headlines.